HALOBETASOL PROPIONATE

N/A

Manufactured by Lacer Pharma, LLC

3,036 FDA adverse event reports analyzed

Last updated: 2026-04-15

About HALOBETASOL PROPIONATE

HALOBETASOL PROPIONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Lacer Pharma, LLC. The most commonly reported adverse reactions for HALOBETASOL PROPIONATE include DRUG INEFFECTIVE, PSORIASIS, PRURITUS, PRODUCT USE IN UNAPPROVED INDICATION, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for HALOBETASOL PROPIONATE.

Top Adverse Reactions

DRUG INEFFECTIVE254 reports
PSORIASIS178 reports
PRURITUS115 reports
PRODUCT USE IN UNAPPROVED INDICATION92 reports
RASH89 reports
FATIGUE70 reports
PAIN68 reports
ARTHRALGIA61 reports
DERMATITIS ATOPIC59 reports
CONDITION AGGRAVATED51 reports
DIARRHOEA51 reports
HEADACHE51 reports
OFF LABEL USE51 reports
COUGH50 reports
DRY SKIN50 reports
SKIN EXFOLIATION50 reports
NAUSEA47 reports
PRODUCT DOSE OMISSION ISSUE45 reports
PAIN IN EXTREMITY43 reports
ERYTHEMA42 reports
INJECTION SITE PAIN42 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE38 reports
ECZEMA36 reports
MALAISE35 reports
PSORIATIC ARTHROPATHY35 reports
DYSPNOEA33 reports
GAIT DISTURBANCE33 reports
COVID 1932 reports
PERIPHERAL SWELLING31 reports
DIZZINESS30 reports
TREATMENT FAILURE30 reports
BACK PAIN27 reports
PNEUMONIA27 reports
HYPERSENSITIVITY26 reports
SKIN LESION26 reports
ASTHENIA24 reports
URTICARIA24 reports
ANXIETY23 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION23 reports
OROPHARYNGEAL PAIN23 reports
ABDOMINAL DISCOMFORT22 reports
BRONCHITIS22 reports
MUSCLE SPASMS22 reports
SKIN FISSURES22 reports
URINARY TRACT INFECTION22 reports
FALL21 reports
SINUSITIS21 reports
INSOMNIA20 reports
JOINT SWELLING20 reports
SLEEP DISORDER20 reports
VOMITING20 reports
MULTIPLE SCLEROSIS19 reports
MUSCULAR WEAKNESS18 reports
MUSCULOSKELETAL STIFFNESS18 reports
PALPITATIONS18 reports
WEIGHT DECREASED18 reports
DEPRESSION17 reports
NASOPHARYNGITIS17 reports
PRODUCT USE ISSUE17 reports
CHEST PAIN16 reports
NONINFECTIVE ENCEPHALITIS16 reports
OEDEMA PERIPHERAL16 reports
SKIN HAEMORRHAGE16 reports
SUSPECTED COVID 1916 reports
ALOPECIA15 reports
BURNING SENSATION15 reports
DRUG HYPERSENSITIVITY15 reports
INCORRECT DOSE ADMINISTERED15 reports
INJECTION SITE ERYTHEMA15 reports
PYREXIA15 reports
SKIN PLAQUE15 reports
UPPER RESPIRATORY TRACT INFECTION15 reports
DEATH14 reports
DECREASED APPETITE14 reports
DRUG ERUPTION14 reports
EMOTIONAL DISTRESS14 reports
HYPERTENSION14 reports
RASH ERYTHEMATOUS14 reports
VISION BLURRED14 reports
ABDOMINAL PAIN UPPER13 reports
BLISTER13 reports
DISCOMFORT13 reports
STOMATITIS13 reports
ACTINIC KERATOSIS12 reports
CONSTIPATION12 reports
DRY EYE12 reports
EPISTAXIS12 reports
EYE PRURITUS12 reports
ILLNESS12 reports
INJECTION SITE SWELLING12 reports
OSTEOARTHRITIS12 reports
PAPULE12 reports
PARAESTHESIA12 reports
ABDOMINAL PAIN11 reports
ATRIAL FIBRILLATION11 reports
CHEST DISCOMFORT11 reports
CHILLS11 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION11 reports
FEELING ABNORMAL11 reports
HEPATIC FUNCTION ABNORMAL11 reports

Report Outcomes

Out of 1,270 classified reports for HALOBETASOL PROPIONATE:

Serious 34.3%Non-Serious 65.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female689 (57.9%)
Male500 (42.0%)
Unknown2 (0.2%)

Reports by Age

Age 5825 reports
Age 6025 reports
Age 6324 reports
Age 5723 reports
Age 5919 reports
Age 5118 reports
Age 5618 reports
Age 5217 reports
Age 5317 reports
Age 5517 reports
Age 6416 reports
Age 7016 reports
Age 3415 reports
Age 6115 reports
Age 4714 reports
Age 6214 reports
Age 6514 reports
Age 6914 reports
Age 5413 reports
Age 6713 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with HALOBETASOL PROPIONATE?

This profile reflects 3,036 FDA FAERS reports that mention HALOBETASOL PROPIONATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for HALOBETASOL PROPIONATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, PSORIASIS, PRURITUS, PRODUCT USE IN UNAPPROVED INDICATION, RASH, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures HALOBETASOL PROPIONATE?

Labeling and FAERS entries often list Lacer Pharma, LLC in connection with HALOBETASOL PROPIONATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.